Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Kwok

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Annals of Translational Medicine|January 25, 2021
Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?Kit Shing, Gerry Kwok, Joanne Chiu, et al.
Human Vaccines & Immunotherapeutics|July 12, 2016
Pembrolizumab (Keytruda)Gerry Kwok, Thomas C C Yau, Joanne W Chiu, et al.
The American Journal of Medicine|March 26, 2014
Pyrexia, massive hepatomegaly, and extreme hyperferritinemiaGerry Kwok, Amanda Kan, Rock Y Y Leung, et al.
Annals of Hematology|September 3, 2013
Macrophage activation syndrome leading to fatality in subcutaneous panniculitis-like T cell lymphomaGerry Kwok, Florence Loong, Chun-Sing Wong, et al.
Advances in Therapy|October 26, 2021
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast CancersBryan Li, Thomas Yau, Roland Leung, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Annals of Translational Medicine|January 25, 2021
Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?Kit Shing, Gerry Kwok, Joanne Chiu, et al.
Human Vaccines & Immunotherapeutics|July 12, 2016
Pembrolizumab (Keytruda)Gerry Kwok, Thomas C C Yau, Joanne W Chiu, et al.
The American Journal of Medicine|March 26, 2014
Pyrexia, massive hepatomegaly, and extreme hyperferritinemiaGerry Kwok, Amanda Kan, Rock Y Y Leung, et al.
Annals of Hematology|September 3, 2013
Macrophage activation syndrome leading to fatality in subcutaneous panniculitis-like T cell lymphomaGerry Kwok, Florence Loong, Chun-Sing Wong, et al.
Advances in Therapy|October 26, 2021
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast CancersBryan Li, Thomas Yau, Roland Leung, et al.
Pageof 1